The rating revision is based on several factors, including Nanticoke’s weakened financial performance and heightened capital spending.
Fitch also affirmed the “BBB-” rating on Nanticoke’s series 2013 revenue bonds, affecting $44.1 million.
More articles on healthcare finance:
Phoebe Putney approves new financial assistance policy
UHS to implement Cerner’s Millennium Revenue Cycle, e-MDs completes McKesson software assets acquisition & more – 7 RCM company key notes
MedAssist, Gaffey Healthcare partner for RCM efficiency: 4 things to know
